Recombinant proteins production in Escherichia coli BL21 for vaccine applications: a cost estimation of potential industrial-scale production scenarios.

MLA

Akmayan, Ilkgul, et al. “Recombinant Proteins Production in Escherichia Coli BL21 for Vaccine Applications: A Cost Estimation of Potential Industrial-Scale Production Scenarios.” Preparative Biochemistry & Biotechnology, vol. 54, no. 7, Aug. 2024, pp. 932–45. EBSCOhost, https://doi.org/10.1080/10826068.2023.2299495.

APA

Akmayan, I., Ozturk, A. B., & Ozbek, T. (2024). Recombinant proteins production in Escherichia coli BL21 for vaccine applications: a cost estimation of potential industrial-scale production scenarios. Preparative Biochemistry & Biotechnology, 54(7), 932–945. https://doi.org/10.1080/10826068.2023.2299495

Chicago

Akmayan, Ilkgul, Abdullah Bilal Ozturk, and Tulin Ozbek. 2024. “Recombinant Proteins Production in Escherichia Coli BL21 for Vaccine Applications: A Cost Estimation of Potential Industrial-Scale Production Scenarios.” Preparative Biochemistry & Biotechnology 54 (7): 932–45. doi:10.1080/10826068.2023.2299495.